HBOX Therapies
HBOX Therapies has developed a technology that facilitates lung-protective treatment of respiratory patients, the patented platform technology HBOX (Hyperbaric Blood Oxygenation). The management team of HBOX Therapies consists of the founders and shareholders Dr. Peter Schlanstein, Dr. Matthias Menne and Niklas Steuer. Before founding the company, they worked together for many years at the Institute for Applied Medical Technology (AME) at RWTH Aachen University and are highly specialized in their fields.
Press releases
Press
MedTech startup HBOX Therapies receives €2.3m in seed funding for protective lung support
The medtech start-up develops innovative treatment method for patients with lung failure.
HBOX Therapies receives €2.3 million in seed funding from TechVision Fonds (TVF), High-Tech Gründerfonds (HTGF) and business angel Prof. Dr. Peter Borges.
The fresh capital will be used to develop and test a first prototype, marking an important step towards clinical trials.
Aachen, 22 February 2023 – HBOX Therapies raises €2.3m in seed funding. The round is led by TVF, with pa
Info & Contact
- E–Mail:
- info@hbox-therapies.com
Address
HBOX Therapies GmbH
Kuhlweg 42
52074 Aachen
Kuhlweg 42
52074 Aachen
In portfolio
02. Feb 2023